The prevalence of heart diseases globally increases the demand for interventional cardiology surgeries. The cardiology surgeries are costly and have some risk factor attached - there is 3-5% probability of patient’s death. The global increase in life style oriented diseases has indirectly put pressure on the economies of the nation. The patient alone does not bear the cost of the treatment. The funding comes from the government health programs, reimbursement policies and health insurances to enable the patient for getting treatment.
US is the largest market for the Cardiovascular surgery devices with 46% of global share. Europe has captured 27% of market share in the cardiovascular surgery devices. APAC has largest growth in the market which mainly comes from the China and Japan.
Key companies profiled include
1. Abbott Cardiovascular
2. Boston Scientific Corp.
3. C.R. Bard, Inc.
4. Cook Medical
5. Medtronic. Inc
6. Toshiba Medical systems
7. Biosense Webster, Inc.
8. Edwards Lifescience Corp.
9. Lombard Medical,
10. Atricure Inc.,
11. Atrium Medical Corporation.,
12. Johnson And Johnson,
13. GE Healthcare (Interventional Imaging) ,
14. Philips Healthcare(Interventional Imaging),
15. Smiths Medical(Interventional Imaging),
16. St. Judes Medical,
17. Hansen Medical,
18. Berlin Heart,
19. Cambridge Heart
1. Abbott Cardiovascular
2. Boston Scientific Corp.
3. C.R. Bard, Inc.
4. Cook Medical
5. Medtronic. Inc
6. Toshiba Medical systems
7. Biosense Webster, Inc.
8. Edwards Lifescience Corp.
9. Lombard Medical,
10. Atricure Inc.,
11. Atrium Medical Corporation.,
12. Johnson And Johnson,
13. GE Healthcare (Interventional Imaging) ,
14. Philips Healthcare(Interventional Imaging),
15. Smiths Medical(Interventional Imaging),
16. St. Judes Medical,
17. Hansen Medical,
18. Berlin Heart,
19. Cambridge Heart
Browse For Full Report: http://www.acutemarketreports.com/report/cardiology-surgical-interventional-cardiology-devices
This Occams Research Report covers
1. Historical data
2. Revenue forecasts, growth rates and CAGR upto 2021
3. Industry Analysis
4. Competitive Analysis
5. Key geographic growth data
6. Deep profiles top competitive companies
1. Historical data
2. Revenue forecasts, growth rates and CAGR upto 2021
3. Industry Analysis
4. Competitive Analysis
5. Key geographic growth data
6. Deep profiles top competitive companies
Chap 1.Executive summary
Chap 2.Market overview
2.1.Market Estimation Methodology
2.2.Value Chain analysis
2.2.1.Suppliers
2.2.2.Manufacturers
2.2.3.Distributors & Retailers
2.2.4.End Users
2.3.Key Buying Criteria
2.3.1.Quality
2.3.2.Price
2.3.3.Availability
2.3.4.Success rate
2.4.Key Strategies
2.4.1.Innovation Is The Key Industry Strategy to Overcome Competition
2.5.Partnerships, acquisitions and mergers
2.6.Product Launch- a make or break marketing strategy
2.1.Market Estimation Methodology
2.2.Value Chain analysis
2.2.1.Suppliers
2.2.2.Manufacturers
2.2.3.Distributors & Retailers
2.2.4.End Users
2.3.Key Buying Criteria
2.3.1.Quality
2.3.2.Price
2.3.3.Availability
2.3.4.Success rate
2.4.Key Strategies
2.4.1.Innovation Is The Key Industry Strategy to Overcome Competition
2.5.Partnerships, acquisitions and mergers
2.6.Product Launch- a make or break marketing strategy
Browse For Same Category: http://www.acutemarketreports.com/category/pharmaceutical-market
Chap 3.Market determinants
3.1.Drivers
3.1.1.Global increase in life style oriented diseases & fatalities
3.1.2.Medical Tourism
3.1.3.Medical Tourism Organizations
3.1.4.Global increase in healthcare spending
3.1.5.Increasing awareness of healthy lifestyle to drive the market
3.2.Restraints
3.2.1.High Cost of Surgeries
3.2.2.Stringent government policies affect Cardiology market growth
3.3.Opportunities
3.3.1.Research and development to explore healthcare robotics
3.3.2.Technological advancements in surgeries
3.3.3.US FDA approved medical devices
3.4.Challenges
3.4.1.High cost and Adoption issues of medical devices for hospitals and clinics
3.4.2.Reliability Issues
3.1.Drivers
3.1.1.Global increase in life style oriented diseases & fatalities
3.1.2.Medical Tourism
3.1.3.Medical Tourism Organizations
3.1.4.Global increase in healthcare spending
3.1.5.Increasing awareness of healthy lifestyle to drive the market
3.2.Restraints
3.2.1.High Cost of Surgeries
3.2.2.Stringent government policies affect Cardiology market growth
3.3.Opportunities
3.3.1.Research and development to explore healthcare robotics
3.3.2.Technological advancements in surgeries
3.3.3.US FDA approved medical devices
3.4.Challenges
3.4.1.High cost and Adoption issues of medical devices for hospitals and clinics
3.4.2.Reliability Issues
Chap 4.Market Segmentation
4.1.Cardiac rhythm management
4.1.1.Cardiac rhythm management devices
4.1.2.ICD: Cardioverter/defibrillators (ICD's)
4.1.3.Atrial Fibrillation
4.1.3.1.Treatment Options for Atrial Fibrillation
4.1.3.2.Cox-Maze Open Heart Procedure
4.1.3.3.Catheter-based Cardiac Ablation Procedure
4.2.Surgery
4.2.1.Coronary arteries bypass grafting (CABG)
4.2.2.Angioplasty
4.2.3.Transmyocardial Laser Revascularization (TMR)
4.2.4.Heart valve Repair/Replacement
4.2.5.Arrhythmia Treatment
4.2.6.Aneurysm Repair
4.2.7.Heart Transplant
4.2.7.1.Surgery to Place Ventricular Assist Devices or Total Artificial Hearts
4.2.8.Open Heart Surgery
4.2.9.Types of open heart surgery
4.2.10.Off Pump Heart surgery
4.2.11.Minimally invasive surgeries
4.3.Imaging Devices
4.3.1.Still Imaging
4.3.2.Real time imaging
4.3.3.Magnetic Resonance Angiogram (MRA)
4.3.4.Fluoroscopy
4.3.5.Echocardiography
4.4.Cardiac Catheterization
4.1.Cardiac rhythm management
4.1.1.Cardiac rhythm management devices
4.1.2.ICD: Cardioverter/defibrillators (ICD's)
4.1.3.Atrial Fibrillation
4.1.3.1.Treatment Options for Atrial Fibrillation
4.1.3.2.Cox-Maze Open Heart Procedure
4.1.3.3.Catheter-based Cardiac Ablation Procedure
4.2.Surgery
4.2.1.Coronary arteries bypass grafting (CABG)
4.2.2.Angioplasty
4.2.3.Transmyocardial Laser Revascularization (TMR)
4.2.4.Heart valve Repair/Replacement
4.2.5.Arrhythmia Treatment
4.2.6.Aneurysm Repair
4.2.7.Heart Transplant
4.2.7.1.Surgery to Place Ventricular Assist Devices or Total Artificial Hearts
4.2.8.Open Heart Surgery
4.2.9.Types of open heart surgery
4.2.10.Off Pump Heart surgery
4.2.11.Minimally invasive surgeries
4.3.Imaging Devices
4.3.1.Still Imaging
4.3.2.Real time imaging
4.3.3.Magnetic Resonance Angiogram (MRA)
4.3.4.Fluoroscopy
4.3.5.Echocardiography
4.4.Cardiac Catheterization
Request For The Sample: http://www.acutemarketreports.com/request-free-sample/48538
About – Acute Market Reports:
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.
Name: Chris Paul
ACUTE MARKET REPORTS
Designation: Global Sales Manager
Toll Free(US/CANADA): +1-855-455-8662
Email: sales@acutemarketreports.com
Website: http://www.acutemarketreports.com
No comments:
Post a Comment